l
leka22

Leon K

@leka22

Medical Science Liaison

Germania
Inglese, Tedesco
Alcune informazioni sono riportate in lingua inglese.
Chi sono
Hi, I'm Leon. I am a Stanford-trained drug discovery scientist with a PhD in Medicinal Chemistry and experience across academia, biotech start-ups, consulting and big pharma. I help professionals and students craft standout CVs, cover letters, LinkedIn profiles, and applications for internships, graduate programs, top universities, and industry roles. Whether you're pursuing your first internship, a career in biotech or pharma, or admission to a highly competitive university, I'll provide honest, personalized feedback to help you present your best self.... Continua a leggere

Competenze

l
leka22
Leon K
offline • 

Consulta i miei servizi

Scrittura del CV
I will review and optimize your resume, CV and cover letter in ivy league style

Esperienza lavorativa

Johnson_& Johnson

Medical Science Liaison

Johnson & Johnson • Full time

Oct 2025 - Present9 mos

Field-based Medical Affairs professional in Oncology with a focus on lung cancer, specifically EGFR-driven non-small cell lung cancer (NSCLC) through antibody and kinase inhibitor treatment. Responsible for strategic scientific exchange and high-impact engagement with leading KOLs, academic investigators, and clinical oncologists, supporting the advancement of oncology programs across development and lifecycle stages. Core responsibilities include driving medical insights generation, enabling data-driven scientific discussions, and supporting clinical development strategy through close collaboration with Clinical Development, Global Medical Affairs, and Commercial teams. Active contributor to external scientific education and internal medical strategy alignment. Therapeutic and functional expertise spans targeted therapies in lung cancer (EGFR-mutant NSCLC), oncology pipeline communication, and clinical evidence generation support, including real-world evidence and investigator-initiated studies (IIS).

Stanford_University

Postdoctoral Scholar

Stanford University • Full time

Feb 2025 - Oct 20258 mos

Chemistry lead for drug discovery projects at the interface of chemistry and biology. Designed and synthesized small molecules and bifunctional degraders (PROTACs/molecular glues). Led SAR efforts on kinase inhibitors, advancing lead compounds toward preclinical candidate nomination and coordinating with CROs to streamline synthetic routes.

Life Science Consultant

Consulting • Part time

Feb 2025 - Jul 20255 mos

+ Conducted >10 interviews with medical oncologists and nuclear medicine KOLs across the US to assess clinical relevance of radioligand therapy in GI cancers. + Evaluated disease landscape across 50+ oncology indications to identify top opportunities for Targeted Radionuclide Therapy (TRT) narrowing down to 3 high-priority indications, guiding the company's preclinical roadmap. + Created stakeholder maps, identified unmet needs, and helped craft field engagement strategy for launch planning